Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02003781
Other study ID # 4-2013-0581
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date October 2013
Est. completion date October 2023

Study information

Verified date July 2018
Source Yonsei University
Contact Sungha Park, MD
Phone 82-2-2228-8455
Email shpark0530@yuhs.ac
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Set the prospective cohort (CMERC-HI) to study the known and novel etiologies and related factors for predicting clinical outcomes in Korean patients with high risk cardiovascular disease.


Recruitment information / eligibility

Status Recruiting
Enrollment 4000
Est. completion date October 2023
Est. primary completion date October 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 80 Years
Eligibility Inclusion Criteria:

- high risk hypertension patients a. eGFR > 60 with one of target organ damages b. eGFR <= 60

- diabetes mellitus with microalbumin ration (AC ratio >= 30mg/g)

- anuric ESRD patients on dialysis

- the relatives of acute myocardial infarction patients under 55 years old (men)/ 65 years old (women)

- atherosclerotic cardiovascular disease (abdominal aorta diameter =3 cm or ankle-brachial index <0.9, or carotid plaque or carotid intima-media thickness =0.9 mm, or asymptomatic old cerebrovascular accident, or >30% stenosis in at least one major coronary artery)

- rheumatoid arthritis patients aged > 40 years on MTX and steroid therapy

- atrial fibrillation patients with CHADS-VASc Score = 1

- kidney transplant recipient at > 3 months after transplantation

Exclusion Criteria:

- acute myocardial infarction, acute coronary syndrome patients, symptomatic coronary artery disease or history of these diseases

- symptomatic peripheral artery disease, heart failure and history of these diseases

- desired life time under 6 months due to non-cardiovascular disease (e.g. cancer, sepsis)

- women with pregnancy or on nursing

- history of contrast allergy and related side effects

- within the first three months after transplantation

- acute renal allograft rejection

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Korea, Republic of Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine Seoul

Sponsors (1)

Lead Sponsor Collaborator
Yonsei University

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Prognosis of high risk cardiovascular disease all-cause mortality, cardiovascular mortality, non-cardiovascular mortality
new onset of acute myocardial infarction, acute coronary syndrome, heart failure, stroke, peripheral artery disease, hospitalization for revascularization and these disease
10 year after recruting